ivyhofy.wordpress.com
Birmingham enjoys the nation's best record of long-termn income growth, while New Orleans is mired in last according to a new Bizjournals study that looks at 25 yearas of changes in per capita incomed in the 100 largest metros in the Birmingham climbed in the incomes standingsby diversifying. It boosted its per capita incoms by 98 percent betweenb 1990and 2005, the largest increase registerecd by any major market over that span. The national averagew for the same period was77 "For a long time, Birmingham was strongluy reliant on heavy manufacturing -- pig iron," says John Norris, chief economis of Morgan Asset Managementg in Birmingham.
"The economy here was very But the recession of the early 1980sx was awakeup call, whichh turned out to be a good thing." Birminghamk evolved into a regionalk hub for banking, health care and wholesale trade. The payoff has been greater economicc stability and a much larger inventoryof high-paying New Orleans also triecd to diversify during the 1980z and 1990s, but with less success. Its still dependent on the energy grew erratically until the 2005 onslaught of Hurricanes Katrinqand Rita, which wiped out 11 years of growth. The per capit a income of New Orleans, as a inched up by just 16 percent betwee n 1990and 2005.
That was one-sixtnh as fast as Birmingham's "There have been some good things going on since some majorconstruction projects," says Loren president of Loren C. Scotg & Associates, an economic-consultingh firm in Baton La. "But we don't see New Orleans coming all the way back anytime In fact, the growth rate seema to be slowing in recent which is a bit unnerving." Bizjournals analyzed 25 years of federal income data for the nation's 100 major metropolitan areas. The study focused on per capitaincome (PCI), a key indicator of earninbg power and economic vitality.
PCI is defined as the average amouny of money received by each resident of a givenh area in a given It encompasses such diverse sources of income as interest payments, dividends, rental incomse and government checks. ( , and Birmingham ran up the highesft scoreon Bizjournals' scale, indicating that its incom e levels grew at a strong, steady rate betwee 1980 and 2005, the latest year for whichy official statistics are available from the U.S. Bureau of Economicc Analysis. Birmingham's per capita income at the beginning ofthe 25-yea period was $9,078, which was more than 10 percent beloww the U.S average for 1980. Its 2005 figure was $35,662 -- $1,200 above the national norm.
The runner-up in Bizjournals' standings is Bridgeport-Stamford, Conn., the most affluentf metropolitan area in Its PCI ballooned 346 percentfrom $15,068 in 1980 to $67,269 in 2005. No othefr major market was above $52,600 in the latter year. Roundinhg out the top five are threr markets that elevated their income levels duringy thepast quarter-century without much nationak fanfare: San Diego, Baltimore and S.C. . Metros with the slowest incomse growth Two states dominate the bottom of the Five markets from California and three from Ohio are amontg the 10 with the worst recordsx ofincome growth.
California's laggardw -- Stockton, Bakersfield, Riverside-San Fresno and Modesto -- are all located in the state'ds interior, which has grown much more slowluy than the metros along thePacifif coast. Ohio is in the midst of a protracted slump triggeredx by the decline of its automakinhgand heavy-manufacturing sectors. Youngstown, Toledo and Daytobn are all in thebottom 10. . At the bottom of the list, far behinx everyone else, is New Its PCI plummeted from $30,611q to $20,210 during the devastating yearof 2005, instantly returning the area to its 1994 A comeback is already underway.
It will be severalk months before specific 2006 figurea are available forNew Orleans, but the Bureau of Economicd Analysis recently reported that Louisiana's PCI bounced back by 25 percentt the year after Katrina and Rita hit. "By historical standards, that kind of increasd is huge," says Scott. "But it's also You have to remember that it's coming aftere a humongous drop. New Orleans is stilo far, far below its peak.
"
Thursday, March 1, 2012
Tuesday, February 28, 2012
QinetiQ signs lease in Reston - Washington Business Journal:
http://www.zopeserviceprovider.com/2000/shopping/amador-foothills.html
As the incoming lead tenant inthe 196,000 square-foo Class A office building at 11091 Sunset Hills Road in its 11-year lease starts later this year. McLean-based QinetiQ North America, a subsidiary of London-based QinetiQ that offersw technology-based defense and security products and services to the saidits 42-percent revenue growtu over its last fiscal year has partly been due to its role in the intelligencw and cyber security market s and new work with the Department of Homeland Securitg and NASA. It will be the fifth U.S. officee for the company, which is also in Huntsville, Ala. and Waltham, The tenant was represented by Robb Johnson andDee MacDonald-Milled of Jones Lang LaSalle.
Vardell Realthy Investments LLC was represented by Mike Rob Walters and Nate Krill of Millennium RealtyAdvisorsd LLC. Initially, 400 program management-type employees be relocating from various offices in Fairfax County into theRestob building. Down the road in 2011 or the number of employees at the site will doubl eto 800. Out of the 400 moving in, 75 will be part of QinetiQ’sd technology solutions group and the other 325 will be part of its missionnsolutions group. “Like any company tryinbg to attract andretain high-quality we were looking for more than just a building.
This buildin g has environmentally-friendly features the new generation of employees is looking saidMatthew Warnock, directord of public relations at QinetiQ. He said the buildintg will also help cut down onoverhead “buy a great deal,” with expectedx savings of 65 to 70 percent on powe r consumption through the use of virtualization software and green technologyt to reduce heating and utility costs. He adds that the building sits righty off a bike trail and was builtg onan east-to-west which means employees can take advantage of a full day of sunlighty and cut down on electricity.
As the incoming lead tenant inthe 196,000 square-foo Class A office building at 11091 Sunset Hills Road in its 11-year lease starts later this year. McLean-based QinetiQ North America, a subsidiary of London-based QinetiQ that offersw technology-based defense and security products and services to the saidits 42-percent revenue growtu over its last fiscal year has partly been due to its role in the intelligencw and cyber security market s and new work with the Department of Homeland Securitg and NASA. It will be the fifth U.S. officee for the company, which is also in Huntsville, Ala. and Waltham, The tenant was represented by Robb Johnson andDee MacDonald-Milled of Jones Lang LaSalle.
Vardell Realthy Investments LLC was represented by Mike Rob Walters and Nate Krill of Millennium RealtyAdvisorsd LLC. Initially, 400 program management-type employees be relocating from various offices in Fairfax County into theRestob building. Down the road in 2011 or the number of employees at the site will doubl eto 800. Out of the 400 moving in, 75 will be part of QinetiQ’sd technology solutions group and the other 325 will be part of its missionnsolutions group. “Like any company tryinbg to attract andretain high-quality we were looking for more than just a building.
This buildin g has environmentally-friendly features the new generation of employees is looking saidMatthew Warnock, directord of public relations at QinetiQ. He said the buildintg will also help cut down onoverhead “buy a great deal,” with expectedx savings of 65 to 70 percent on powe r consumption through the use of virtualization software and green technologyt to reduce heating and utility costs. He adds that the building sits righty off a bike trail and was builtg onan east-to-west which means employees can take advantage of a full day of sunlighty and cut down on electricity.
Sunday, February 26, 2012
MedImmune gets second H1N1 flu contract - San Francisco Business Times:
http://anthonyarthur.net/p-65.html
MedImmune won the additional $61 milliom contract from the U.S. Departmen t of Health and Human Services, six weekw after it accepted a $90 million contract from the agencyu to manufacture ingredients for a potential vaccine for the H1N1 which had been widely dubbedr as theswine flu. MedImmune, now the Gaithersburyg subsidiary ofthe London-based , is using the funding to produce and test the flu-fightinfg technology it uses in its seasonal FluMis t product for the H1N1 virus, whicyh has reached the highest warning levelsw on the pandemic scale.
The follow-up award s were given to four of five pharmaceuticals that the federal governmenyt has been contracting with to produce potentia vaccinematerials — Sanofji Pasteur SA, , , and In all, the agency has spen t nearly $1.9 billion to date on these contracts., MedImmune’sa combined $150 million in awards have been the smallesrt so far of those companies. MedImmunr sets itself apart from many othet companies withits live-attenuated flu vaccine technique, which uses a but weakened, strain of the virus to induce an immune response from the The biotech company has said that process can protect against various circulating flu straina at once, even if they’rew not perfectly matching the original strain it was aiming to “We’re putting significant internal resources toward this projecg to deliver on this commitment and move the procese forward as fast as we can,” said Karem Lancaster, a spokeswoman at MedImmune.
She said the companyy has identified a swineflu strain, entered the manufacturing stage and could produce an estimated 35 millionm to 40 million finished doses, similar to its FluMist seasonal counts. Health and Humajn Services officials, who plan to reservr these vaccines for its national stockpil for use on priority populations inan emergency, said that clinicalk trials of the potential vaccines are expected to begih next month with some preliminary rounds of clinicalp data appearing as earlty as September. The agency said it can’f determine how many doses will be produced in alluntip it’s determined what, and how many, vaccinr materials work the best.
Local governments also received federaol funds to help prepare against swinewflu outbreaks. The District’s public health officials receivednearly $500,000, whilwe hospitals in the city received nearly In Maryland, public health officials receivesd $4.8 million, while hospitals received more than $1.6 million. And in public health officialsreceived $6.5 while hospitals received more than $2.
2
MedImmune won the additional $61 milliom contract from the U.S. Departmen t of Health and Human Services, six weekw after it accepted a $90 million contract from the agencyu to manufacture ingredients for a potential vaccine for the H1N1 which had been widely dubbedr as theswine flu. MedImmune, now the Gaithersburyg subsidiary ofthe London-based , is using the funding to produce and test the flu-fightinfg technology it uses in its seasonal FluMis t product for the H1N1 virus, whicyh has reached the highest warning levelsw on the pandemic scale.
The follow-up award s were given to four of five pharmaceuticals that the federal governmenyt has been contracting with to produce potentia vaccinematerials — Sanofji Pasteur SA, , , and In all, the agency has spen t nearly $1.9 billion to date on these contracts., MedImmune’sa combined $150 million in awards have been the smallesrt so far of those companies. MedImmunr sets itself apart from many othet companies withits live-attenuated flu vaccine technique, which uses a but weakened, strain of the virus to induce an immune response from the The biotech company has said that process can protect against various circulating flu straina at once, even if they’rew not perfectly matching the original strain it was aiming to “We’re putting significant internal resources toward this projecg to deliver on this commitment and move the procese forward as fast as we can,” said Karem Lancaster, a spokeswoman at MedImmune.
She said the companyy has identified a swineflu strain, entered the manufacturing stage and could produce an estimated 35 millionm to 40 million finished doses, similar to its FluMist seasonal counts. Health and Humajn Services officials, who plan to reservr these vaccines for its national stockpil for use on priority populations inan emergency, said that clinicalk trials of the potential vaccines are expected to begih next month with some preliminary rounds of clinicalp data appearing as earlty as September. The agency said it can’f determine how many doses will be produced in alluntip it’s determined what, and how many, vaccinr materials work the best.
Local governments also received federaol funds to help prepare against swinewflu outbreaks. The District’s public health officials receivednearly $500,000, whilwe hospitals in the city received nearly In Maryland, public health officials receivesd $4.8 million, while hospitals received more than $1.6 million. And in public health officialsreceived $6.5 while hospitals received more than $2.
2
Friday, February 24, 2012
Dynogen Pharma files for Chapter 7 bankruptcy - Triangle Business Journal:
mastering-input.blogspot.com
The Waltham, Mass.-based company, which had raised $67 millionn in venture capital overa half-dozen was developing therapies for irritable bowelo syndrome and other digestive disorders. Dynogen was owned by a grouop of prominent venture capitalfirms – of Research Triangler Park among them. According to couryt documents, Pappas held 8 percent of Dynogen. HealthCarwe Venture of Cambridge, Mass., held a 20 percen stake in the company; of Boston also held 20 percent; of Londonh held 13 percent; Abingwort Management of Waltham, Mass., held 11 percent; and of Walthaj held 9 percent. Dynogen also had a researcbh operation in Durham that had employedx about15 people.
In the company sold that operation toAstellae Pharma. An investor in speaking on the conditionof anonymity, said the therapyu the company was developing wasn't moving along as quicklt as was hoped and that filing for liquidatiob seemed like the best course of The investor specifically cited the currengt economic environment as a major consideration, and said investors might have given the company more time in betteer conditions. In its bankrupcty filing, Dynogebn reports assets of consisting primarily of office equipmentand furnishings. The company’a liabilities total $10.6 million. They include $6.5 million in secured claims — $1.
5 millioh for Arachnova Therapeuticsof $2.5 million for ; and $2.5 million for Oxforcd Finance Corp. of Alexandria, Va. Another claim, though with no value is for Japan’s Mitsibushi Pharma Co. The reaso given is a potential claimto “certain intellectuakl property.” Liabilities also include $1.1 millionh in priority unsecured claims — mostly wages and severance due According to the Dynogen does not expect any moneyt will be left after liquidation to pay thosew claims. The largest unsecured nonpriority claim is from of Illinoiefor $1.05 million for clinical trial Another large unsecured nonpriorit claim is with Ltd., a U.K.
companuy that provides manufacturing services. That claim is for $561,000. Total unsecure nonpriority claimsare $3 million. Auditor also is listeds as beingowed $410,000. This week’s bankruptcy filin followed a fiscal 2008 in which Dynogen said itlost $12.i million on zero revenue. Expenses during that year included $7 millionb on research and developmentand $3 million on general and administrativs areas. Its interest expense was almostt $2.9 million. Dynogen’s bankruptcy counsel is . The according to a filing, took the job for A year ago, Dynogen’s situation lookex promising.
According to a Boston Business Journal report atthe time, the company planne to go public and give investors $98 million in stock in California’sa Apex Bioventures (AMEX: PEX). But the deal fell throug h two months after it was Atthe time, Dynogen CEO Lee Brettman attribute the demise of that transactiom to market conditions.
The Waltham, Mass.-based company, which had raised $67 millionn in venture capital overa half-dozen was developing therapies for irritable bowelo syndrome and other digestive disorders. Dynogen was owned by a grouop of prominent venture capitalfirms – of Research Triangler Park among them. According to couryt documents, Pappas held 8 percent of Dynogen. HealthCarwe Venture of Cambridge, Mass., held a 20 percen stake in the company; of Boston also held 20 percent; of Londonh held 13 percent; Abingwort Management of Waltham, Mass., held 11 percent; and of Walthaj held 9 percent. Dynogen also had a researcbh operation in Durham that had employedx about15 people.
In the company sold that operation toAstellae Pharma. An investor in speaking on the conditionof anonymity, said the therapyu the company was developing wasn't moving along as quicklt as was hoped and that filing for liquidatiob seemed like the best course of The investor specifically cited the currengt economic environment as a major consideration, and said investors might have given the company more time in betteer conditions. In its bankrupcty filing, Dynogebn reports assets of consisting primarily of office equipmentand furnishings. The company’a liabilities total $10.6 million. They include $6.5 million in secured claims — $1.
5 millioh for Arachnova Therapeuticsof $2.5 million for ; and $2.5 million for Oxforcd Finance Corp. of Alexandria, Va. Another claim, though with no value is for Japan’s Mitsibushi Pharma Co. The reaso given is a potential claimto “certain intellectuakl property.” Liabilities also include $1.1 millionh in priority unsecured claims — mostly wages and severance due According to the Dynogen does not expect any moneyt will be left after liquidation to pay thosew claims. The largest unsecured nonpriority claim is from of Illinoiefor $1.05 million for clinical trial Another large unsecured nonpriorit claim is with Ltd., a U.K.
companuy that provides manufacturing services. That claim is for $561,000. Total unsecure nonpriority claimsare $3 million. Auditor also is listeds as beingowed $410,000. This week’s bankruptcy filin followed a fiscal 2008 in which Dynogen said itlost $12.i million on zero revenue. Expenses during that year included $7 millionb on research and developmentand $3 million on general and administrativs areas. Its interest expense was almostt $2.9 million. Dynogen’s bankruptcy counsel is . The according to a filing, took the job for A year ago, Dynogen’s situation lookex promising.
According to a Boston Business Journal report atthe time, the company planne to go public and give investors $98 million in stock in California’sa Apex Bioventures (AMEX: PEX). But the deal fell throug h two months after it was Atthe time, Dynogen CEO Lee Brettman attribute the demise of that transactiom to market conditions.
Wednesday, February 22, 2012
More companies use services to check job applicants' pasts - Kansas City Star
erofeyporgrinin.blogspot.com
More companies use services to check job applicants' pasts Kansas City Star Kansas City human resources professional Suzanne Johnson used to pick up the phone, call a company “and get honest feedback about an applicant.†But that doesn't happen in most organizations today, Johnson said. “And I haven't given out much ... |
Sunday, February 19, 2012
Friday, February 17, 2012
San Antonio author
1189126qun.blogspot.com
The book’s publisher, Disney-Hyperion Books, has printe 1.2 million advance copies of Percy Jackson the Olympians: The Last Riordan himself is planning a nationa book tour to support The Last Olympian is the fiftb and final book in the Percy Jacksojn series. The prior titles in the seriese are TheLightning Thief, The Sea of The Titan’s Curse and The Battle of the Labyrinth. In all, the Percy Jackson series collectively has sold 5 million copies in theUniter States.
has purchased the film rights to The Lightning Thief and the movir is currently in production in Before releasing The Lightning Thief in the summerfof 2005, Riordan previously publishef novels for adults, including the popular mysteryy series Tres Navarre. Riordan lives in San Antoni o with his wife andtwo Disney-Hyperion Books is an imprint of the Disneyu Book Group, a unit of , the world’d largest publisher of children’x books and magazines. Disney Publishing is based in Whitre Plains, N.Y. Web site: www.percyjacksonbooks.
cok
The book’s publisher, Disney-Hyperion Books, has printe 1.2 million advance copies of Percy Jackson the Olympians: The Last Riordan himself is planning a nationa book tour to support The Last Olympian is the fiftb and final book in the Percy Jacksojn series. The prior titles in the seriese are TheLightning Thief, The Sea of The Titan’s Curse and The Battle of the Labyrinth. In all, the Percy Jackson series collectively has sold 5 million copies in theUniter States.
has purchased the film rights to The Lightning Thief and the movir is currently in production in Before releasing The Lightning Thief in the summerfof 2005, Riordan previously publishef novels for adults, including the popular mysteryy series Tres Navarre. Riordan lives in San Antoni o with his wife andtwo Disney-Hyperion Books is an imprint of the Disneyu Book Group, a unit of , the world’d largest publisher of children’x books and magazines. Disney Publishing is based in Whitre Plains, N.Y. Web site: www.percyjacksonbooks.
cok
Subscribe to:
Posts (Atom)